The Genetically Modified Organisation

June, 2016    SMM-145 The Genetically Modified Organisation To paraphrase Darwin, it is not the strongest nor most intelligent life science company that will survive, it is the one most able to change. Yet many companies find it very difficult to...

A Frugal Future

May, 2016    SMM-143 A Frugal Future Looking at the future of the life science industry, it’s evident that value will dominate the industry environment. As a result, free-spending life science companies will be replaced by frugal, ruthlessly...

GSK’s Morality Gene

April, 2016    SMM-142 GSK’s Morality Gene GSK’s recent decisions about pricing, transparency and return on investment seem to indicate an interesting new adaption to market conditions, one that is likely to be followed by the industry. This...

Sexual selection

March, 2016    SMM-141 Sexual selection By focusing on a particular trait when we interview candidates for a position in our organisation, we may open ourselves up to unintended consequences, neglecting the full range of routines we...

J&J’s Portent of Purity

February, 2016    SMM-139 J&J’s Portent of Purity There is a new pattern of shareholder pressure across the sector, leading to new corporate structures being seen to emerge.